MC2149A1 - INTERFER WITH STABILIZED LEUKOCYTAIS - Google Patents

INTERFER WITH STABILIZED LEUKOCYTAIS

Info

Publication number
MC2149A1
MC2149A1 MC902149A MC2149A MC2149A1 MC 2149 A1 MC2149 A1 MC 2149A1 MC 902149 A MC902149 A MC 902149A MC 2149 A MC2149 A MC 2149A MC 2149 A1 MC2149 A1 MC 2149A1
Authority
MC
Monaco
Prior art keywords
leukocytais
interfer
stabilized
stabilized leukocytais
Prior art date
Application number
MC902149A
Other languages
French (fr)
Inventor
Ferro Alberto
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2149A1 publication Critical patent/MC2149A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC902149A 1989-09-28 1990-09-24 INTERFER WITH STABILIZED LEUKOCYTAIS MC2149A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
MC2149A1 true MC2149A1 (en) 1992-03-10

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902149A MC2149A1 (en) 1989-09-28 1990-09-24 INTERFER WITH STABILIZED LEUKOCYTAIS

Country Status (26)

Country Link
EP (1) EP0420049B1 (en)
JP (1) JPH03130232A (en)
KR (1) KR910005886A (en)
CN (1) CN1050503A (en)
AR (1) AR244551A1 (en)
AT (1) ATE92334T1 (en)
AU (1) AU636653B2 (en)
CA (1) CA2024046A1 (en)
CZ (1) CZ277712B6 (en)
DD (1) DD298054A5 (en)
DE (1) DE59002183D1 (en)
FI (1) FI904756A7 (en)
HU (1) HU205555B (en)
IE (1) IE903479A1 (en)
IL (1) IL95769A0 (en)
IS (1) IS3631A7 (en)
MC (1) MC2149A1 (en)
MX (1) MX22522A (en)
MY (1) MY106615A (en)
NO (1) NO904218L (en)
NZ (1) NZ235153A (en)
PH (1) PH27531A (en)
PT (1) PT95454A (en)
RU (1) RU2008017C1 (en)
YU (1) YU184090A (en)
ZA (1) ZA907579B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
WO1997041885A1 (en) * 1996-05-09 1997-11-13 Feronpatent Limited Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
EP1007083A1 (en) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
PL193286B1 (en) * 1998-03-26 2007-01-31 Schering Corp Formulations for protection of peg-interferon alpha conjugates
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
CN1175901C (en) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 Stable water solution of interferon
EP1796647B1 (en) 2004-08-12 2010-08-11 Schering Corporation Stable pegylated interferon formulation
DE102004048379A1 (en) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Spring element made of sputtered shape memory alloy
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (en) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd Method for purifying α- and β-interferon
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
ATE31023T1 (en) * 1983-04-28 1987-12-15 Armour Pharma PHARMACEUTICAL PREPARATION CONTAINING PURIFIED FIBRINONECTIN.
DE3484374D1 (en) * 1983-08-04 1991-05-08 Green Cross Corp GAMMA INTERFERON COMPOSITION.
PT82249B (en) * 1985-03-25 1988-01-07 Schering Corp Process for preparing stable gamma-interferon formulations
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
RU2008017C1 (en) 1994-02-28
NZ235153A (en) 1993-03-26
EP0420049A1 (en) 1991-04-03
DE59002183D1 (en) 1993-09-09
CA2024046A1 (en) 1991-03-29
AU6309890A (en) 1991-04-11
CS432890A3 (en) 1992-12-16
YU184090A (en) 1992-09-07
HUT56284A (en) 1991-08-28
DD298054A5 (en) 1992-02-06
FI904756A0 (en) 1990-09-27
HU205555B (en) 1992-05-28
MX22522A (en) 1993-10-01
FI904756A7 (en) 1991-03-29
EP0420049B1 (en) 1993-08-04
ZA907579B (en) 1991-06-26
HU906021D0 (en) 1991-03-28
CZ277712B6 (en) 1993-03-17
MY106615A (en) 1995-06-30
CN1050503A (en) 1991-04-10
PT95454A (en) 1991-05-22
JPH03130232A (en) 1991-06-04
IL95769A0 (en) 1991-06-30
AU636653B2 (en) 1993-05-06
NO904218L (en) 1991-04-02
PH27531A (en) 1993-08-18
NO904218D0 (en) 1990-09-27
AR244551A1 (en) 1993-11-30
IE903479A1 (en) 1991-04-10
KR910005886A (en) 1991-04-27
ATE92334T1 (en) 1993-08-15
IS3631A7 (en) 1991-03-29

Similar Documents

Publication Publication Date Title
DK0396968T3 (en) combine
FR2632154B1 (en) COMBINE
KR900006738A (en) microwave
DK348289A (en) RELATIONS
ATA247090A (en) TERMINAL ARRANGEMENT
BR9001646A (en) ORNAMENTAL ZIPER
NO914160D0 (en) STABILIZED VISMUTOXIDE
BR8906323A (en) COMPRESSOR SET
DE69029227D1 (en) Sliding component
MC2149A1 (en) INTERFER WITH STABILIZED LEUKOCYTAIS
DE59107890D1 (en) Deck oven
FR2645561B3 (en) EXTENSIBLE STRUCTURE
DK0400327T3 (en) combine
FI912776A7 (en) Oven
FR2632837B1 (en) EXTENSIBLE SHELF-LIBRARY
DK160889D0 (en) MICROWAVE
FI895670A7 (en) Rifle
IT8922436A0 (en) TACTICAL HEADBOARD
DK378689A (en) quinazoline
KR890021349U (en) Oven
KR900006273U (en) Oven
KR900006272U (en) Oven
KR900001013U (en) Microwave
SE8800044D0 (en) HIGH AND LOW BATH FLAT
KR910012050U (en) Microwave case structure

Legal Events

Date Code Title Description
YP Annual fee paid